Ken Griffin Statera Biopharma, Inc. Call Options Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
Call Options
1 transactions
Others Institutions Holding STAB
# of Institutions
4Shares Held
30KCall Options Held
0Put Options Held
0-
Dowling & Yahnke LLC San Diego, CA28.9KShares$00.0% of portfolio
-
Tucker Asset Management LLC Littleton, CO1KShares$00.0% of portfolio
-
Four Thought Financial, LLC Venice, FL125Shares$00.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Statera Biopharma, Inc.
- Ticker STAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,295,700
- Description
- Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...